Editorial Standards

Last updated: June 2025

Our Core Commitment

GLP1Place.com is built on a premise that the research peptide and GLP-1 space is severely underserved by quality educational content. Our editorial standards exist to ensure that what we publish is accurate, compliant, honestly evidenced, and genuinely useful for researchers — not engagement-optimized noise.

Source Requirements

All factual claims on compound profiles, research articles, and hub pages must be sourced to:

• Peer-reviewed studies indexed in PubMed, MEDLINE, or equivalent databases
• FDA approval records, trial registries (ClinicalTrials.gov), or regulatory filings
• Published meta-analyses or systematic reviews
• Original research papers from named institutions

Wikipedia, vendor websites, blog posts, anecdotal reports, and social media are not accepted as primary sources. They may be noted as context but are never cited as evidence.

Evidence Tier System

Every compound profile includes an evidence tier badge indicating the quality of available research:

• Tier I — Human Phase II/III randomized controlled trial data
• Tier II — Human observational studies, Phase I trials, or approved-elsewhere human data
• Tier III — Animal (in vivo) preclinical models
• Tier IV — Cell culture (in vitro) or mechanistic/theoretical only

Tier badges reflect the best available evidence for the compound, not a claim that effects observed in one tier will translate to humans or other contexts.

Compliance Language Standards

We do not use the following language anywhere on this platform:

• “Take this,” “inject this,” “use this,” or any directive administration language
• “Best peptide for [goal],” “most effective for [condition],” or comparative efficacy claims
• “This cures,” “this treats,” “this prevents,” “this heals,” or disease mitigation language
• “Recommended dose,” “optimal dose,” “beginner dose,” or any dosage recommendation framing
• “FDA approved” for any compound that is not actually, verifiably FDA-approved
• “Safe,” “no side effects,” “well-tolerated” without peer-reviewed context

We prefer language like: “studied for,” “investigated in published research,” “reported in preclinical models,” “mechanism under investigation,” and “not a recommendation.”

AI-Assisted Content Policy

Some content on this platform may be AI-assisted in drafting. All AI-drafted content is:

• Reviewed by a human editor before publication
• Fact-checked against primary sources
• Labeled with content status in admin (Draft / Needs Review / Reviewed)
• Never published with the AI-draft label without editorial review

Corrections Policy

We correct factual errors promptly. If you identify an inaccuracy, cite a source, or have a correction to submit, contact us at support@glp1place.com. Significant corrections are noted on the relevant page with a correction date.

Conflict of Interest

GLP1Place.com may link to affiliated vendor sites. These relationships are fully disclosed in our Disclaimer. Vendor relationships do not influence compound profiles, evidence tiers, or editorial content. Compounds are not ranked, promoted, or reviewed differently based on vendor relationships.